MALDEN, Mass., Sept. 18, 2021 /PRNewswire-PRWeb/ -- AxioMed
continues to press its advantages in the artificial total disc
replacement market with its investment in lateral lumbar
viscoelastic disc technology. At a time when revenues and margins
are driving the spine industry, AxioMed chose to venture alone into
developing a lateral lumbar viscoelastic disc replacement.
We thank the United States Patent and Trademark Office (USPTO)
for recognizing this unique, differentiated viscoelastic disc
replacement technology and giving us their approval for this
patent.
KICVentures Group CEO and Board-Certified Orthopedic Spine
Surgeon and Professor Dr. Kingsley R.
Chin says "there is a sense of urgency in commercializing
the AxioMed cervical, lumbar and lateral lumbar viscoelastic disc
replacements internationally".
About AxioMed
AxioMed was founded in 2001 by surgeons at Cleveland Clinic and
engineers who previously worked with Dr. Art Steffee and Acroflex viscoelastic disc
replacement. The current AxioMed disc comprises of a proprietary
silica-based viscoelastic material proven in extensive
biomedical/biocompatible testing to mimic the human disc in all
planes and 50+ years of longevity testing. The viscoelastic
material is radiolucent and thus X-ray and MRI compatible. Over 800
discs have been implanted worldwide with zero failures or
revisions. It is the only viscoelastic lumbar disc to complete a
USA IDE clinical study with 10+
years of follow-up.
http://www.AxioMed.com
About KICVentures Group
Founded in 2000 makes us the most experienced healthcare investment
holding company with the largest portfolio of medical device
technologies focused on solutions for less invasive outpatient
spine surgery. Our investment strategy is to acquire or invent
disruptive technologies using our own capital or partner with
private individual investors. This allows us the freedom to make
quick and nimble decisions such as when we acquired AxioMed
Viscoelastic Disc Technologies while other firms invested in
ball-and-socket articulating spacers.
http://www.KICVenturesGroup.com
Media Contact
KICVentures Group, KICVentures Group, 267-342-3968,
Investor@KICVentures.com
Kingsley R Chin MD, KICVentures Group, 6176975442,
kingsleychin@KICVentures.com
SOURCE KICVentures Group